
Abigail Louise Vanhorn
Examiner (ID: 16074)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1616, 1609, 1636 |
| Total Applications | 1398 |
| Issued Applications | 583 |
| Pending Applications | 147 |
| Abandoned Applications | 713 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20414349
[patent_doc_number] => 12497622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
[patent_app_type] => utility
[patent_app_number] => 17/612912
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44915
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1564
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612912 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | May 20, 2020 | Issued |
Array
(
[id] => 16282626
[patent_doc_number] => 20200276228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/875735
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875735 | IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES | May 14, 2020 | Pending |
Array
(
[id] => 16282626
[patent_doc_number] => 20200276228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/875735
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875735 | IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES | May 14, 2020 | Pending |
Array
(
[id] => 17735022
[patent_doc_number] => 20220220481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => LIPID OLIGONUCLEOTIDE ANTISENSE AGAINST ANTIBIOTIC RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 17/609591
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609591 | LIPID OLIGONUCLEOTIDE ANTISENSE AGAINST ANTIBIOTIC RESISTANCE | May 6, 2020 | Pending |
Array
(
[id] => 16253600
[patent_doc_number] => 20200262974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => SUSTAINED RELEASE COMPOSITION USING BIOBASED BIODEGRADABLE HYPERBRANCHED POLYESTERS
[patent_app_type] => utility
[patent_app_number] => 16/868339
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868339
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868339 | Sustained release composition using biobased biodegradable hyperbranched polyesters | May 5, 2020 | Issued |
Array
(
[id] => 16252210
[patent_doc_number] => 20200261584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => STABILIZED PROTEIN GEL PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/868291
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868291 | STABILIZED PROTEIN GEL PREPARATION | May 5, 2020 | Abandoned |
Array
(
[id] => 16791776
[patent_doc_number] => 20210121593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => GREEN BIN ODOR REDUCTION COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/857044
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/857044 | GREEN BIN ODOR REDUCTION COMPOSITION AND USE THEREOF | Apr 22, 2020 | Abandoned |
Array
(
[id] => 16282625
[patent_doc_number] => 20200276227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/842341
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842341 | IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES | Apr 6, 2020 | Abandoned |
Array
(
[id] => 16204825
[patent_doc_number] => 20200237815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Methods for treatment of lung damage and for inhibition of lung fibrosis
[patent_app_type] => utility
[patent_app_number] => 16/873379
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16873379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/873379 | Methods for treatment of lung damage and for inhibition of lung fibrosis | Mar 31, 2020 | Abandoned |
Array
(
[id] => 16612113
[patent_doc_number] => 20210030766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/832700
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832700 | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF | Mar 26, 2020 | Abandoned |
Array
(
[id] => 16627681
[patent_doc_number] => 20210046334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHODS FOR FIXING HAIR AND SKIN
[patent_app_type] => utility
[patent_app_number] => 16/830789
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16830789
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/830789 | Methods for fixing hair and skin | Mar 25, 2020 | Issued |
Array
(
[id] => 16341559
[patent_doc_number] => 20200306209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHOD OF TREATING ACID-BASE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/829607
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 130370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/829607 | METHOD OF TREATING ACID-BASE DISORDERS | Mar 24, 2020 | Abandoned |
Array
(
[id] => 16175386
[patent_doc_number] => 20200222354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
[patent_app_type] => utility
[patent_app_number] => 16/826938
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826938 | PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE | Mar 22, 2020 | Abandoned |
Array
(
[id] => 17611943
[patent_doc_number] => 20220154222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NOVEL NUCLEIC ACID MODIFIERS
[patent_app_type] => utility
[patent_app_number] => 17/439159
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439159
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439159 | NOVEL NUCLEIC ACID MODIFIERS | Mar 12, 2020 | Abandoned |
Array
(
[id] => 17611943
[patent_doc_number] => 20220154222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NOVEL NUCLEIC ACID MODIFIERS
[patent_app_type] => utility
[patent_app_number] => 17/439159
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439159
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439159 | NOVEL NUCLEIC ACID MODIFIERS | Mar 12, 2020 | Abandoned |
Array
(
[id] => 16748779
[patent_doc_number] => 20210100788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => PALONOSETRON FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/813044
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813044 | PALONOSETRON FORMULATIONS AND USES THEREOF | Mar 8, 2020 | Abandoned |
Array
(
[id] => 16482146
[patent_doc_number] => 20200375746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => Methods, Compositions and Articles for Improving Joint Lubrication
[patent_app_type] => utility
[patent_app_number] => 16/808931
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808931
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808931 | Methods, Compositions and Articles for Improving Joint Lubrication | Mar 3, 2020 | Abandoned |
Array
(
[id] => 17688139
[patent_doc_number] => 20220195431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/432237
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432237 | COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION | Feb 20, 2020 | Pending |
Array
(
[id] => 16267182
[patent_doc_number] => 20200268669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/790009
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790009
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790009 | Compositions and methods for the treatment and prophylaxis of surgical site infections | Feb 12, 2020 | Issued |
Array
(
[id] => 17227202
[patent_doc_number] => 20210353758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => MICROCARRIER FOR EMBOLIZATION AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/286925
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286925 | MICROCARRIER FOR EMBOLIZATION AND PREPARATION METHOD THEREFOR | Jan 28, 2020 | Abandoned |